Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001683168-25-003345
Filing Date
2025-05-09
Accepted
2025-05-09 15:35:22
Documents
55
Period of Report
2025-02-28

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO 1 cannabis_i10qa-022825.htm   iXBRL 10-Q/A 574357
2 CERTIFICATION cannabis_ex3100.htm EX-31 10418
3 CERTIFICATION cannabis_ex3200.htm EX-32 3810
  Complete submission text file 0001683168-25-003345.txt   3215406

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cbih-20250228.xsd EX-101.SCH 27918
5 XBRL CALCULATION FILE cbih-20250228_cal.xml EX-101.CAL 40256
6 XBRL DEFINITION FILE cbih-20250228_def.xml EX-101.DEF 83881
7 XBRL LABEL FILE cbih-20250228_lab.xml EX-101.LAB 205897
8 XBRL PRESENTATION FILE cbih-20250228_pre.xml EX-101.PRE 169331
59 EXTRACTED XBRL INSTANCE DOCUMENT cannabis_i10qa-022825_htm.xml XML 361185
Mailing Address 6201 BONHOMME ROAD SUITE 435S HOUSTON TX 77036
Business Address 6201 BONHOMME ROAD SUITE 435S HOUSTON TX 77036 214-733-0868
Cannabis Bioscience International Holdings, Inc. (Filer) CIK: 0001411057 (see all company filings)

EIN.: 844901229 | Fiscal Year End: 0531
Type: 10-Q/A | Act: 34 | File No.: 333-146758 | Film No.: 25930016
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)